http://www.prnewswire.com/news-releases/247276781.html www.prnewswire.com/news-releases/frost--sullivan-applauds-gbdbios-disruptive-tb-read-poc-diagnostics-specifically-for-developing-countries-247276781.html /biomedical-diagnostics-support /biomedical-diagnostics-support /biomedical-diagnostics-support
Infectious Disease Rapid Diagnostics, Global Disease Detection, TB Diagnostics Test

A Breakthrough in TB Diagnostics

Our breakthrough biophotonic detection platform utilizes Reporter Enzyme Fluorescence to detect live TB bacteria. The technology offers the potential to increase the sensitivity of detection by orders of magnitude over current widely available diagnostics in endemic settings. Through a Co-Development partnership with the Foundation for Innovative New Diagnostics (FIND), we are developing our GBD TB REaD™ POC diagnostic assay that offers the potential to be the world’s first true Point-of-Care TB diagnostic. Learn More

 

Our Philosophy

  • Constraint-Based Innovation
    Designing for the needs of resource constrained environments.
  • Collaborative Partnerships
    Working with experts in global health to inform design of products that are low-cost, easy-to-use and rapid.
  • High Quality
    Pursue highest quality standards in development and manufacturing.
  • Humble Service
    Passionate dedication to improving lives through better diagnostics.
  • Learn More

 

Our Partners